Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Voliotis

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Molecular Systems Biology|December 20, 2024
Oncogenic PIK3CA corrupts growth factor signaling specificityRalitsa R Madsen, Alix Le Marois, Oliwia N Mruk, et al.
ACS ES&T Air|January 15, 2026
Changes in Secondary Organic Aerosol Composition and Volatility Going from a Low to a High HO<sub>2</sub>/RO<sub>2</sub> Regime in α‑Pinene PhotooxidationVeronica Geretti, Yarê Baker, Thomas Bannan, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|July 12, 2002
Management of disease-related anemia in patients with multiple myeloma or chronic lymphocytic leukemia: epoetin treatment recommendationsHeinz Ludwig, Kanti Rai, Joan Blade, et al.
European Journal of Cancer (Oxford, England : 1990)|January 14, 2012
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: subset analyses of the phase III Sorafenib Asia-Pacific trialAnn-Lii Cheng, Zhongzhen Guan, Zhendong Chen, et al.
Journal of Hepatology|June 26, 2012
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trialJordi Bruix, Jean-Luc Raoul, Morris Sherman, et al.
Cancer|August 24, 2005
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrenceRichard A Larson, Eric L Sievers, Edward A Stadtmauer, et al.
The Lancet. Oncology|December 20, 2008
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trialAnn-Lii Cheng, Yoon-Koo Kang, Zhendong Chen, et al.
The Journal of Clinical Investigation|November 16, 2020
Kisspeptin receptor agonist has therapeutic potential for female reproductive disordersAli Abbara, Pei Chia Eng, Maria Phylactou, et al.
The New England Journal of Medicine|July 25, 2008
Sorafenib in advanced hepatocellular carcinomaJosep M Llovet, Sergio Ricci, Vincenzo Mazzaferro, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Molecular Systems Biology|December 20, 2024
Oncogenic PIK3CA corrupts growth factor signaling specificityRalitsa R Madsen, Alix Le Marois, Oliwia N Mruk, et al.
ACS ES&T Air|January 15, 2026
Changes in Secondary Organic Aerosol Composition and Volatility Going from a Low to a High HO<sub>2</sub>/RO<sub>2</sub> Regime in α‑Pinene PhotooxidationVeronica Geretti, Yarê Baker, Thomas Bannan, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|July 12, 2002
Management of disease-related anemia in patients with multiple myeloma or chronic lymphocytic leukemia: epoetin treatment recommendationsHeinz Ludwig, Kanti Rai, Joan Blade, et al.
European Journal of Cancer (Oxford, England : 1990)|January 14, 2012
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: subset analyses of the phase III Sorafenib Asia-Pacific trialAnn-Lii Cheng, Zhongzhen Guan, Zhendong Chen, et al.
Journal of Hepatology|June 26, 2012
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trialJordi Bruix, Jean-Luc Raoul, Morris Sherman, et al.
Cancer|August 24, 2005
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrenceRichard A Larson, Eric L Sievers, Edward A Stadtmauer, et al.
The Lancet. Oncology|December 20, 2008
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trialAnn-Lii Cheng, Yoon-Koo Kang, Zhendong Chen, et al.
The Journal of Clinical Investigation|November 16, 2020
Kisspeptin receptor agonist has therapeutic potential for female reproductive disordersAli Abbara, Pei Chia Eng, Maria Phylactou, et al.
The New England Journal of Medicine|July 25, 2008
Sorafenib in advanced hepatocellular carcinomaJosep M Llovet, Sergio Ricci, Vincenzo Mazzaferro, et al.
Pageof 9